Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies

Ray, KK; Del Prato, S; Muller-Wieland, D; Cariou, B; Colhoun, HM; Tinahones, FJ; Domenger, C; Letierce, A; Mandel, J; Samuel, R; Bujas-Bobanovic, M; Leiter, LA

Ray, KK (reprint author), Imperial Coll, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, London SW7 2AZ, England.

CARDIOVASCULAR DIABETOLOGY, 2019; 18 (1):

Abstract

BackgroundIndividuals with diabetes often have high levels of atherogenic lipoproteins and cholesterol reflected by elevated low-density lipoprotein c......

Full Text Link